GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Total Long-Term Assets

Ascelia Pharma AB (OSTO:ACE) Total Long-Term Assets : kr58.14 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Ascelia Pharma AB's Total Long-Term Assets for the quarter that ended in Dec. 2023 was kr58.14 Mil.

Ascelia Pharma AB Total Long-Term Assets Historical Data

The historical data trend for Ascelia Pharma AB's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Total Long-Term Assets Chart

Ascelia Pharma AB Annual Data
Trend Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Assets
Get a 7-Day Free Trial 57.34 59.05 58.88 57.70 58.14

Ascelia Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.70 58.99 58.72 58.38 58.14

Ascelia Pharma AB Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Ascelia Pharma AB Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Ascelia Pharma AB's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascelia Pharma AB (OSTO:ACE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Total Long-Term Assets
Comparable Companies
XSAT:CESSA OSTO:NXTCL OSTO:LIPUM OSTO:SIMRIS B OSTO:BIOVIC B OSTO:ALZ OSTO:ZICC OSTO:ELIC NGM:GTAB B OSTO:XINT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
7ZA:Germany
Address
Hyllie Boulevard 34, Malmo, SWE, SE-215 32
Website
https://www.ascelia.com
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

Ascelia Pharma AB (OSTO:ACE) Headlines

No Headlines